Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma
Min Hwan Kwak, Min Woo Lee, Seong Eun Ko, Hyunchul Rhim, Tae Wook Kang, Kyoung Doo Song, Jong Man Kim, Gyu-Seong Choi
Ultrasonography. 2022;41(3):543-552.   Published online 2022 Feb 9     DOI:
Citations to this article as recorded by Crossref logo
2022 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for Local Ablation Therapy of Hepatocellular Carcinoma: What’s New?
Min Woo Lee, Jeong Min Lee, Young Hwan Koh, Jin Wook Chung
Korean Journal of Radiology.2023; 24(1): 10.     CrossRef
Ablative strategies for recurrent hepatocellular carcinoma
Lin Wang, Bao-Xian Liu, Hai-Yi Long
World Journal of Hepatology.2023; 15(4): 515.     CrossRef
Comparison of laparoscopic radiofrequency ablation with percutaneous radiofrequency ablation in the treatment of chronic hepatitis B-related hepatocellular carcinoma involving specific sites: A retrospective cohort study
Wei Dai, Shuo Fang, Cong Mo, Yuxin Liu, Tingyun Shen, Mingyi Li, Honglian Zhou, Huilai Miao, Ming Chen, Xiaoyu Tan, Shiting Bao, Xiaohong Xu, Nianping Chen
Asian Journal of Surgery.2023;[Epub]     CrossRef
Fusion imaging-guided radiofrequency ablation with artificial ascites or pleural effusion in patients with hepatocellular carcinomas: the feasibility rate and mid-term outcome
Jae Hyun Kim, Jae Young Lee, Su Jong Yu, Dong Ho Lee, Ijin Joo, Jung-Hwan Yoon, Yoon Jun Kim, Jeong Hee Yoon, Jeong Min Lee
International Journal of Hyperthermia.2023;[Epub]     CrossRef
Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma
Anna Podlasek, Maheeba Abdulla, Dieter Broering, Khalid Bzeizi
Cancers.2023; 15(13): 3347.     CrossRef